Panacea Medical

Kolar, India Founded: 1999 • Age: 27 yrs Minicorn
Radiotherapy and mammography devices are developed for medical use.

About Panacea Medical

Panacea Medical is a Healthcare company based in Kolar (India) founded in 1999 by Raghu Padmanabhan and G V Subrahmanyam. Radiotherapy and mammography devices are developed for medical use. Panacea Medical has raised $28.63 million across 14 funding rounds from investors including NEA, Tara Fund and Claypond Capital. The company has 373 employees. Panacea Medical was last valued at $76.26 million in January 2025. Its chief executive, as recorded, is Raghu Padmanabhan. Its website panaceamedical.in draws about 18 thousand monthly visits. Its Indian entity Panacea Medical Technologies Private Limited reported revenue of β‚Ή99.58 Cr. Panacea Medical offers products and services including Siddharth II, Bhabhatron 3i, Lilac Digital Mammography, Bhabhatron MLC, and Lilac FFDM with Tomosynthesis. Its focus areas include Life Sciences, Women Health, Medical Devices and Screening Devices.

Company details

Panacea was founded in 1999 and is located in Kolar, India, within the medical devices sector. Radiotherapy equipment, including gamma therapy units Bhabhatron MLC and Bhabhatron 3, is manufactured. An advanced simulator called Imagin is produced, alongside Siddharth II for stereotactic imaging and Impact for patient immobilization. Mammography systems such as Lilac 2DC, Lilac 2DD, and Lilac are also developed for diagnostic applications.

Key Metrics
  • Annual Revenue
    ₹99.58 Cr

    FY 2025 · +1% YoY

  • Net Profit
    ₹6.67 Cr

    FY 2025 · 7% margin

  • EBITDA
    ₹20.14 Cr

    FY 2025 · 20% margin

  • Total Equity Funding
    $28.63M (USD)

    in 14 rounds

  • Investors
    NEA

    & 4 more

  • Employee Count
    373

Products & Services of Panacea Medical

Panacea Medical offers a comprehensive portfolio of products and services, including Siddharth II, Bhabhatron 3i, Lilac Digital Mammography, Bhabhatron MLC, and Lilac FFDM with Tomosynthesis.

Siddharth II
Radiotherapy Equipment

Provides radiation therapy for oncology treatments

Bhabhatron 3i
Radiotherapy Equipment

Offers advanced cobalt therapy for cancer care

Lilac Digital Mammography
Radiology Equipment

Enables digital imaging for women's health diagnostics

Bhabhatron MLC
Radiotherapy Equipment

Delivers precise radiation for tumor treatment

Lilac FFDM with Tomosynthesis
Radiology Equipment

Supports detailed mammography for early detection

Apps and channels of Panacea Medical

its YouTube channel Panacea Medical Technologies Pvt. Ltd. has 536 subscribers and 30 videos.

Panacea Medical Technologies Pvt. Ltd.
YouTube 536 subscribers 30 videos Science & Technology
Open channel

Videos from Panacea Medical

The most watched videos on Panacea Medical's YouTube channel, Panacea Medical Technologies Pvt. Ltd. (536 subscribers). Click a video to play it here.

Panacea's Manufacturing Facility - rooted in Engineering and Science to create Oncology solutions
6.9K views
Siddharth II-Ring Gantry Linear Accelerator, a revolutionary LINAC for all Radiation Oncology needs.
5.5K views
Bhabhatron MLC
2.4K views
Mammograms on the move with Lilac Mammography Unit
2.3K views

More on Panacea Medical Technologies Pvt. Ltd..

Funding Insights of Panacea Medical

Panacea Medical has successfully raised a total of $28.63M across 14 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $28.63M
  • Total Rounds 14
  • First Round $3.23M

    (Dec 2013)

  • Investors Count 5

Latest 10 of 14 funding rounds of Panacea Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2026Debt – Conventional––
Nov 2025$1.13MSeries E––
–
Jan 2025$5.8MSeries B$76.26MClaypond Capital
–
Jan 2025$5.8MSeries D––
–
Oct 2023$1.5MDebt – Conventional––
May 2022$628,201Debt – Conventional––
Aug 2019$1.93MSeries B$23.91MNew Enterprise Associates
–
Aug 2019$1.93MSeries C–New Enterprise Associates
–
Mar 2018$384,178Debt – Conventional––
Jan 2017$3.66MSeries B$β€’β€’β€’β€’β€’Tara Fund
Valuation history
DateValuationStage
Jan 2025$76.26Mβ€’β€’β€’β€’β€’β€’β€’β€’
Aug 2019$23.91Mβ€’β€’β€’β€’β€’β€’β€’β€’
Jan 2017$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Apr 2016$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Dec 2013$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Panacea Medical

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $76.26M (Jan 2025). 5 investors in total: 5 institutional.

Investors in Panacea Medical

Panacea Medical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NEA, Tara Fund and Claypond Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
Single family office of Ranjan Pai, chairman of the Manipal Education and Medical Group
An investment management firm providing strategic financial solutions.
2006tarafund.comLalitpur, Nepal
tdb.gov.in
dst.gov.in
Premium access

Investor details for Panacea Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Panacea Medical Technologies Private Limited (Panacea Medical)

Panacea Medical Technologies Private Limited is the primary company behind Panacea Medical. The board of Panacea Medical Technologies Private Limited currently have 7 directors; the longest-serving is Venkata Subrahmanyam Goteti, appointed in 1999. 17 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Venkata Subrahmanyam Goteti
DIN 02338270
Managing Director26 Mar 199927 yrs 7 moPanacea Medical Technologies Private Limited
Ramann Yerramilli
DIN 02043813
Director25 Sep 200323 yrs 1 moPanacea Medical Technologies Private Limited
Satyalakshmi Goteti
DIN 03029412
Director22 Sep 200521 yrs 1 moPanacea Medical Technologies Private Limited
Nagavalli Goteti
DIN 02488568
Director20 Apr 200818 yrs 6 moPanacea Medical Technologies Private Limited
Shravan Subramanyam
DIN 00695586
Nominee Director22 Feb 20251 yr 8 moPanacea Medical Technologies Private Limited
Chandra Sekhar Reddy Garisa
DIN 03057784
Nominee Director22 Feb 20251 yr 8 moPanacea Medical Technologies Private Limited
Sunil Kumar Khurana
DIN 06642212
Nominee Director02 May 20251 yr 6 moPanacea Medical Technologies Private Limited

People of Panacea Medical

8 people are tracked at Panacea Medical (4 in leadership, 4 in team); the tracked headcount is 373.

NameRoleGroup
Raghu Padmanabhan
Co-Founder & CEOLeadership
G V Subrahmanyam
Co-Founder & Managing DirectorLeadership
Animesh Vatsyaya
VP, Marketing & SalesLeadership
GVS Manyam
Managing DirectorLeadership
Pallavi T.S
Sr. Regional Manager - BDTeam
Prashanth Krishnan JS
Senior Regional Manager-Business DevelopmentTeam
Yadhu Krishna
Senior Engineer - Business DevelopmentTeam
Monisha Elangovan
Sales AnalystTeam
Premium access

Complete people profiles for Panacea Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Panacea Medical

Figures of Panacea Medical Technologies Private Limited, the primary company behind Panacea Medical, for FY 2025. Revenue was ₹99.58 Cr (+1% year on year). Net profit was ₹6.67 Cr (7% margin). EBITDA was ₹20.14 Cr (20% margin). Revenue has grown at a compounded annual rate of +28% over three years and +48% over five years.

  • ₹99.58 CrRevenue · FY 2025 · +1% YoY
  • ₹6.67 CrNet profit · 7% margin
  • ₹20.14 CrEBITDA · 20% margin
  • ₹39.39 CrPaid-up capital
  • 373Employees (provident fund records)
  • +28%Revenue CAGR, 3 years
  • +48%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Panacea Medical Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Panacea Medical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Panacea Medical

4 dated milestones of Panacea Medical across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Panacea Medical is founded.
  2. Funding First funding round of $3.2M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Debt – Conventional,.

Web traffic of Panacea Medical

The website of Panacea Medical (panaceamedical.in) receives about 17.9K visits a month.

  • Monthly visits
    17.9K

    ▲ 155.4% vs previous month

Similar websites

Websites whose visitors overlap most with Panacea Medical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
panaceainfosec.com
100%
2.7K#5,785,438View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Panacea Medical

Premium access

Complete news archive for Panacea Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Panacea Medical

Panacea Medical was founded in 1999 and raised its 1st funding round 14 years after it was founded.

Panacea Medical is headquartered in Kolar, India. It is registered at Kolar, Karnataka, India.

Raghu Padmanabhan is the CEO of Panacea Medical, as recorded in our data. They have also founded this company.

Panacea Medical is a funded company, having raised a total of $28.63M across 14 funding rounds to date. The company's 1st funding round was a Series B of $3.66M, raised on Dec 2013.

Panacea Medical has 373 employees.

The primary company behind Panacea Medical, Panacea Medical Technologies Private Limited, reported revenue of β‚Ή99.58 Cr for FY 2025, up 1% year on year.

Panacea was founded in 1999 and is located in Kolar, India, within the medical devices sector. Radiotherapy equipment, including gamma therapy units Bhabhatron MLC and Bhabhatron 3, is manufactured. An advanced simulator called Imagin is produced, alongside Siddharth II for stereotactic imaging and Impact for patient immobilization. Mammography systems such as Lilac 2DC, Lilac 2DD, and Lilac are also developed for diagnostic applications.

Panacea Medical offers Siddharth II, Bhabhatron 3i, Lilac Digital Mammography, Bhabhatron MLC, and Lilac FFDM with Tomosynthesis.

Panacea Medical has 5 investors. Key investors include NEA, Tara Fund, Claypond Capital, Technology Development Board, and Department of Science & Technology.

The valuation of Panacea Medical is $76.26M as of Jan 2025.

Panacea Medical operates through Panacea Medical Technologies Private Limited.

The legal entities of Panacea Medical currently have 8 directors, including Satyalakshmi Goteti, Venkata Subrahmanyam Goteti, Elizabeth Wilson and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available